TuHURA Biosciences, Inc.
HURA
$0.68
-$0.01-1.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 67.87% | -56.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.61% | -14.84% | |||
| Operating Income | -12.61% | 14.84% | |||
| Income Before Tax | 25.42% | -42.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.42% | -42.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.42% | -42.91% | |||
| EBIT | -12.61% | 14.84% | |||
| EBITDA | -12.51% | 14.86% | |||
| EPS Basic | 34.42% | -39.19% | |||
| Normalized Basic EPS | -11.03% | 17.81% | |||
| EPS Diluted | 34.42% | -39.19% | |||
| Normalized Diluted EPS | -11.03% | 17.81% | |||
| Average Basic Shares Outstanding | 13.72% | 2.65% | |||
| Average Diluted Shares Outstanding | 13.72% | 2.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.34% | 0.30% | |||